ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,619Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 2343

$1.48M Total Retail Price of All Prescriptions

Rank: 25 out of 2343

877 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 877 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 877 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 22,962 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 1,487 1,264 1 2
OMEPRAZOLE 1,078 875 2 4
AMLODIPINE BESYLATE 1,018 884 3 5
SIMVASTATIN 746 609 4 1
METOPROLOL TARTRATE 743 686 5 7
FUROSEMIDE 602 488 6 6
PRAVASTATIN SODIUM 491 457 7 15
WARFARIN SODIUM 477 443 8 8
LISINOPRIL 474 391 9 3
ATORVASTATIN CALCIUM 460 388 10 10
TORSEMIDE 401 351 11 157
SERTRALINE HCL 370 310 12 20
GLIMEPIRIDE 335 296 13 45
POTASSIUM CHLORIDE 329 284 14 18
MIRTAZAPINE 327 292 15 41
HYDROCHLOROTHIAZIDE 308 258 16 11
NEXIUM 306 244 17 33
ATENOLOL 305 275 18 12
METFORMIN HCL 303 253 19 9
HYDROCODONE-ACETAMINOPHEN 301 239 S3 20 13
CITALOPRAM HBR 281 216 21 17
PANTOPRAZOLE SODIUM 268 203 22 22
KLOR-CON M20 256 246 23 44
NAMENDA 252 252 24 36
GABAPENTIN 251 178 25 16
OXYCODONE-ACETAMINOPHEN 250 200 S2 26 49
POLYETHYLENE GLYCOL 3350 250 210 26 54
JANTOVEN 236 215 28 81
TRAMADOL HCL 229 200 29 25
ISOSORBIDE MONONITRATE ER 227 227 30 32
ALLOPURINOL 212 197 31 31
SYNTHROID 210 195 32 40
CYMBALTA 206 152 33 74
VENLAFAXINE HCL ER 199 145 34 87
RANITIDINE HCL 198 174 35 43
ZOLPIDEM TARTRATE 190 140 36 24
DIOVAN 187 148 37 23
METHYLPREDNISOLONE 187 148 37 122
PREDNISONE 173 156 39 37
DONEPEZIL HCL 170 160 40 21
LABETALOL HCL 169 158 41 153
DOXAZOSIN MESYLATE 163 152 42 98
LOSARTAN POTASSIUM 163 142 42 19
MELOXICAM 151 95 44 68
ALENDRONATE SODIUM 149 145 45 28
CLOPIDOGREL 141 124 46 26
AZITHROMYCIN 139 101 47 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 139 138 47 151
LEVOFLOXACIN 139 108 47 106
CEPHALEXIN 138 104 50 111
TRIAMTERENE-HCTZ 136 101 51 57
TRAZODONE HCL 135 105 52 53
NIFEDIPINE ER 130 130 53 89
ADVAIR DISKUS 125 103 54 34
QUETIAPINE FUMARATE 125 103 54 77
TAMSULOSIN HCL 120 105 56 29
FENTANYL 120 99 S2 56 69
SPIRIVA 117 97 58 48
METOPROLOL SUCCINATE 116 109 59 14
SPIRONOLACTONE 114 109 60 65
AMLODIPINE BESYLATE-BENAZEPRIL 108 86 61 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 92 62 42
DILTIAZEM 24HR ER 106 98 62 76
LOSARTAN-HYDROCHLOROTHIAZIDE 103 97 64 64
CIPROFLOXACIN HCL 102 85 65 72
IBUPROFEN 101 56 66 75
CYCLOBENZAPRINE HCL 100 37 R 67 109
CEFUROXIME 100 83 67 193
BUSPIRONE HCL 98 70 69 146
OLANZAPINE 97 77 70 121
SINGULAIR 97 65 70 100
CARVEDILOL 96 74 72 27
LANTUS 94 58 73 51
OXYCODONE HCL 91 31 S2 74 67
JANUVIA 89 89 75 50
BACLOFEN 89 29 75 161
PROPRANOLOL HCL 87 64 77 132
CELEBREX 87 76 77 71
CLOTRIMAZOLE-BETAMETHASONE 87 81 77 127
DIGOXIN 86 72 80 35
PLAVIX 85 76 81 38
HUMALOG 85 49 81 131
METFORMIN HCL ER 84 77 83 88
DOXYCYCLINE HYCLATE 82 68 84 180
BENICAR 81 68 85 93
SPS 81 58 85 452
DETROL LA 81 64 85 150
EXELON 79 79 88 129
FELODIPINE ER 75 66 89 116
CRESTOR 72 68 90 30
CARBIDOPA-LEVODOPA 72 72 90 85
VERAPAMIL ER 71 65 92 95
CLONIDINE HCL 71 54 92 70
NOVOLOG 71 53 92 110
DIVALPROEX SODIUM 70 45 95 105
ACETAMINOPHEN-CODEINE 69 61 S3 96 112
PROAIR HFA 68 41 97 86
FLUCONAZOLE 68 46 97 393
FAMOTIDINE 68 53 97 60
DILTIAZEM 24HR CD 67 53 100 83
SYMBICORT 65 50 101 167
LEVETIRACETAM 64 44 102 104
IRBESARTAN 64 64 102 270
AMOX TR-POTASSIUM CLAVULANATE 64 48 102 160
ONGLYZA 63 63 105 211
SSD 62 61 106 364
LYRICA 61 39 107 135
AMITRIPTYLINE HCL 61 41 R 107 117
PAROXETINE HCL 61 42 107 66
BETHANECHOL CHLORIDE 57 54 110 349
ESCITALOPRAM OXALATE 57 49 110 55
DICLOFENAC SODIUM 55 42 112 155
QUINAPRIL HCL 54 48 113 73
LANTUS SOLOSTAR 53 35 114 101
NIFEDICAL XL 53 53 114 148
DEXILANT 52 38 116 184
VANCOMYCIN HCL 51 47 117 348
BENICAR HCT 51 49 117 156
RESTASIS 50 49 119 450
LUNESTA 50 46 119 389
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 42 119 120
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.